Liver Transplantation in a Hemophiliac by Lewis, JH et al.
I 
Vol. 312 ~D. 13 
~. Levy lA. H,'ffman AD. Kramer S~L Land" lA. Shimabukuro 1M. ()<;hlro 
LS. Isolation oi lymphocYlOpathlc retrovlru<.es from San Francisco pallen!> 
willi AIDS. 5.:,ence 1984: 225:I\.W-2. 
5. Bam:-Sinou,,, F. Mathur-Wa~h C. Rey F. et aI. [solation oflym~nop­
athY-Jissociated virus (LAV) and detrction of LA V anti bodie, from- US 
patients with AIDS. JAMA 1985: 253:1737-9. 
o. Curran JW. uwrence ON. Jaffe- H. et aI. Acquired immunodeficiency 
syndrome, AIDS) associated with transfusions. N Engl J Med 1984: 310:69-
75. 
7. Llndesman SH. Ginzburg HM. Weiss SH. The AIDS epidemic. N Engl J 
Med 1985: 312:521-5. -
8. Provisional Pubic Health Service inter-agency recommendations for screen-
ing donated-blood and plasma for antibody to the virus causong acquired 
immunodeficiency syndrome. MMWR 1985: 34:1-5. 
9. Samgadharan MG. Popovic M. Bruch_ L. xhiipb_ach J. Gallo RC. Anti-
bodies reacm·e with a human T-Iymphotropic retrovirus (HTLV-JHI in the 
<.erum of patient' \!'ith AIDS. Science 1984: 224:506-8. 
10. Weiss SH. Goeden JJ. Sarn~adharaA MG. et aI. Screening test for HTLV-
III (AIDS agent) antibodies: specificity. sensitivity-and applications. JAMA 
1985: 253:221-5. . 
11. Schiipbach 1. Haller O. Yogt M. et aI_ Antibodies to H11.V-JII in Swiss 
patients v.i!h AIDS and pre-AIDS and iA groups at rislc for AIDS_ N En~1 J 
Med 1985: 312:265-70. . 
12. Marwiclc C. Use of AIDS alJtibody test may provide more answers. JAMA . 
1985; 253:1694-9_ . 
13. Carlson LHinrichs S. Bryant M. et 01. H1l.V-JIJ antibody screening of 
blood bank donors. Lancet 1985: 1:523-4. 
i4. Sch.iipbach J_ PopovIc M. Gilden RJ. GondaMA. Saingadharan MG. Gallo 
RC. Serological analysis of a sub~up of human T.lymphotropic retrovi· 
ruses (HTLV-IJI)J1ssociated with AIDS. Science 1984; 224:503-5_ 
15. Antibodies ,o-a retrovirus etiologically associated with acquired immunode· 
ficiency syndrome_(AIDS) in populations with increased incidences of the 
syndrome. !>t\lWR 1984; 33:377-9. 
16. Salahuddin SZ. Groopman JE. Markham PD. et aJ. H1l.V III in symptom-
free seronegative persons. Lancet 1984: 2:1418·20. 
17. Pindyck J. Waldman A. Zang E. Oleszko W. Lowy M. BiancoC. Measures 
to decrease the risk of acquired immunodeficiency syndrome IrallSmission 
by blood transfusion. Transfusion 1985; 25:3·9. 
18. Prevention of acquired immune deficiency syndrome (AJDS): repln of 




MALONE -Stt'pht'n Jost'ph ~falont', M.D., of Pocasset. died on 
Sl"ptember 20. He was 94. -
Dr. Malone graduatt'd from Tufts Collt'ge Medical School in 
1927. He was a membt'r oftht' Amt'rican Medical Association and a 
50-yt'ar mt'mbt'r of the Massachust'tls ~{edical Socit't~·. 
OSTERHELD - Rogt'r Goldt'n Qstt'rheld, M.D., of Palmt'r, died 
on Septembt'r '17. Ht' was 88. 
Dr. OSIt'rheld graduatt'd from Boston Univrrsity School of 
~lt-dicine in 1')24. He was a memher of thr Aml"rican Psvchiatric 
Ass'K'iation .lnd a 'IO-war m .. mh(·r of the !\lassachus(,lls 1\ledical 
Soci,·ty. 
ROSt:NilLl'W - Harry Aaron Rost'nhlum. M.D .• formt'rly of 
Worct'strr. dird on January 22. He was 79. 
Or. Rosrnhlum recl"ivrd his dl"grer from the Kansas Cit, L1ni~'rr­
,itv "I' Phv,i"ians ;ond Sur'll't'"s in I~n'l. Hr was a memhrr "f thr 
.\lIwri,·;\O 1\1.·dic,,1 A,,, ... iatioll. th .. Amrri(·an :\LI(h-nt' "f(;.·tI('ral 
I'rani ... • .. ",,1 tI ... ;\" ... ri(·;111 (;,·ro.ltrics S",·i,·lv. 
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CORRESPONDENCE 
Letters to the Editor are considered for publication (subject 
to editing and abridgment), provided that they are submitted 
in duplicate, signed by all authors, type,.Titten in double spac. 
ing. and do not exceed 40 typewritten lines ot manuscript 
text (excluding references). Submission of a letter constitutes-
pe.rmission for the Mas.sachusetts MediCal Society, its licen· 
sees, and its assignees to u~ it in thejo"ntol's various editions 
(print, data- base, and optiaJ disk) in anthologies. revisions, 
and any other fonn or medium. Ldtrrs should not duplicate 
similar material being submitted or published elsewhere, and 
they-should not contain abbreviations. Financial associations 
or other possible conflicts of interest sh.ould always be dis-
dosed. 
Letters referring to -a Tecentjo_IIrfIal article must be received 
_ within six weeks -of the article's publication. We are unable to 
. provide pre.publicati9D proofs, and unpublished material will 
not be returned to authors unless a stamped, self-addressed 
envelope is enclosed. 
LIVER TR.-\:'I:SPLA:XTATIO~ IX .-\ HE~fOPHILIAC 
To-th, Editor: A cure rather than a treatment has long bet'n th~ 
goal of those caring for and those suffering. fro_m hemophilia. En-
couraging results were obtained some years ago with the ttansplan-
tation of normal livers into a dog. ",;th mild hemophilia 1.2 and imo 
four others with severe hemophilia.] Two dogs given transplants 
survived more than 100 days and produced coagulation factor VIII 
in quantities sufficient [0 maimain normal levels. 
The first "cure" in a human bt'ing appurs to have been achieved. 
at least temporarily. in a 15·year-old boy with hemophilia and se-
vere chronic active hepatitis. who recei"ed a liver from a g-year-old 
"normal" donor on March 5, 1985. The patient was given the diag-
nosis of hemophilia A .in early childhood and has been followed at 
the Hemophilia Center, Childrrn's ~femorial Hospital. Northwest-
ern School of~fedicine. Chicago. b,· Dr.John Paul Scott. In 1969 he 
had severe hepatitis B; positivity lor hepatitis B surface antigen and 
antibody to hepatitis B e has JX'rsisted. In addition, therapy·rdated 
non A.non B ht'patitis mav have contributed to his liver dist'ase. 
Aboul four months befort' liver transplantation. a splenectomy was 
performed for chronic thrombocytoJX'nia. which r:esolved postop-
eratively. but a residual pancreaticogastrocutaMous fistula re-
mained. Liver transplantation and rt'pair of the fistula wert' accom: 
plished wiih Ir!!.s than th~ averal(e blood loss. Befor~, during, and for 
18 hours after liver transplanKltion. the patient's facto~ VI II level 
was mainiained at 0.54 to 1.60 l' per millilitrr by intermittent 
infusions of heat-treated factor \'111 concentrate. From 18 hours 
after operation to tht' time of this writing (April 17), his level has 
been sustained at 1.0 to 3.0 l' per milliliter without exogenous 
treatment. The high postoperative levels off actor VIII are similar 
to those seen after transplantation in patit'nts without hemophilia. 
Eight days after operatien the patient underwent repair of a bile 
duct. There was no increased hemorrhage, and he required no fac-
tor vln treatment. 
Although in this case, at least temporarily, internal production of 
factor VII I has bl'en achieved by the implanted liver, liver trans-
plantation cannot bt' recommended as a "cure" for hemophilia. This 
drastic operation is justified only for t'nd-stagt' liver disease bt'cause 
ofthl' risks of lift' long immunosuppressive therapy. ·rejection. infec-
tion. and recurrenc!" of disease. The duration of prod uction offactor . 
VIII is unknown. This cast' sug~rsts that thl" antihemophilic acti\"-
ity (fl,nnr \,111:(;) ofth .. largr factor \'111 complrx. synthrsized in 
('ndnthclium.'·' is acquirrd in Ihr livcr. 
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BLOOD DO!'<ATlO~ BY PERSO:-';S AT HIGH RISK OF .\IOS 
To IIr, ErJilor: In March 1983, th~ U.S: Public H~alth S~rvice 
published guidelinr-s on the prevention ofth~ acquired immunoddi-
.~iency syndromr- (AIDS). including a recommendation that persons 
in groups at high risk of AIDS voluntarily refrain from donating 
blood. I The incubation pr-riod in adult casesoftransfusion-associal-
ed AIDS ranges from two to fi\'~ years.~ Thus, it is not surprising 
that the numb~r of cas~ of transfusion-associat~ AIDS has in-
creased from 9 to 115 since the guidelines were published. ' -3 In 
January 1985, th~ Public Health Service recommendrd that all do-
nated blood be lest~ for antibodi~s to human T-cell Iympholrop-
ic virus Type III (HTLV-III),' th~ primary etiologic agent of 
AIDS,5.8 Since HTLV-I11 is occasionallv isolated from antibodv-
negative sexual partners ofpalients with .~IDS,9 the original guid~-
- lines must still bt' followed strictly.-
Two groups of homosexual men who had been enrollt'd irr private 
physicians' effices in ~fanhattan and Washington. D.C .. during the 
spring of 19828 .'0.11 were surY~':d about their blood-donation prac-
tices during the prelious two years. Eight (4 per cent) of the 199 
homosexual men had donat~ a lotal of 18.units of blood Ixtween 
January 1982 and June 1984: se\'en men donated II units during 
1982, three donated 4'units during 1983, and two donated 3 units 
during 1984. :'I:one of the eight blood donors had HTL\"-III anti-
bodies detected in serum samples obtained in 1982. and none of 
them has acquir~ .... 105. One subject had Iymphadenopath,·, and 
another had both lymphadenopathy and a low helper T -c~lI count 
at the initial examinalion. Thes~ two men were th~ only blood 
donors who had HTLV-III antibodies bv 1984. Thev h~d each 
donated onCe. in August 1982 and May 1982, respecti~·e1y. 
Homosexual men are apparently continuing to donale blood, al-
beil at a reduced rale. Although the assay for HT.LV-III anlibodies 
is verY sensitive and specific 12 and seropositivity is closely associat-
. ed with lymphadenopathy and low helper T-cell counts both· in 
. homosexual men and in patients with hemophilia,B.1l lymphad-
enopathy does occasioiJaily prec~e seroconversion.8.1-4 supJX?rting 
the existence of an antibody-negativ~ carrier state.9 The public 
should be educated'about the potential harm of transfusing blood 
from possible carrienof HTLV-I~I, including not- onJy persons 
from known risk groups but also their heterosexual partn~.rs. I~ As 
the eviden.ce mounts that sexual transmission of HTL V -II I is con-
tinuing, consideration may need to be given to recoqnnendi~ that 
- promiscuous het~rosexual men and women, particularly prostitutes, 
and the~r contacts also refrain froni donating blood.'6 
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ON VASCULAR :-';ON-DISEASE OF THE FOOT 
IN DIABETES 
To III, ErJi/or: \\'t' were interested in the paper by LaGerfo and 
Coffman 1111 f{)(lt riis('ilst" in riiabett's {Dt'c. 20 issud' 
In a prospective stud\" we recently measur~ skin oxygenation of 
the foot in dia~tic patients with ulcerative foot lesions and retinal 
microangiopathy but without macrovascular occ/usin disease in-
ducing permanent ischemia. 
Systolic blood pressure in the gr~at toe was measur~ with.a 
mercury strain gauge on the toe tip and an inAatable thin plaslic cuff 
around the proximal phalanx (Plethysmograph SP2, ~f~imatic, 
Copenhagen).2 Transcutaneous measurement of partial pressure of 
oxygen (POz) was performed with a modified Clark electrode. heat-
ing the skin at -HOC. All measurements were perform~ on the 
dorsum of the foot between the first and second metatarsals (Oxy~ 
gen Monitor, Kontron, Roche}.3 Arterial POz_was measured by 
puncture of the femoral artery. The POz gradient between arterial 
blood and skin was calculated: 
We selected 23 diabetic patients in whOm systolic blood pressure 
in the great toe was above 50 mm Hg, inorder to eliminate those 
..... ith ischemia of the foot due to macrovascular occlusive disease. 
Thirteen of these patients had chronic ulcerative lesiOllsefthe fee\.-
·Eight nondia~tic subjects constituted the control group. 
The P02 gradient ~tween arterial blood and foot skin measur~ 
24.6:t 18.1 mm Hg (mean :t I S.D.) in dia~tic patieil&s with foot 
ulcerations; 2O.4:t 10.5 mm Hg in dia~tic patients. without skin 
ulcerations, and 20.1 :t 10.6 mm Hg·in normal subjects. Differences 
were not statistically significant. . _ 
These data strongly suggest ·that d1a~tic microangiopatbv does 
not provoke microvascular· occlusive d~ea~ and induce a severe 
skin hypoxia. This study is in good agreement ,,;th LoGerfo and 
Coffman's conclusion that diabetic n~uropathy, rather than micro-_ 
\'ascular disease, is the main cause of ulcerative lesions in palitnts 
without foot ischemia due to macrovascular occlusjve disease. 
.1211 Geneve 4'-S~tzerland 
B. KRAHENBUHl" M.D. 
A. MOSSAZ, M.D. 
Hopital Cantonal Universitaire 
de G~neve 
.-. LaGeno FW. Coffman JD, Vascular and microvascular disease of the foot in 
diabct~: implications (or foot care. N Engl J Med 19S4: 311:1615-9, 
2. lassen NA, Krahenbuhl B, Hirai M. Occlusion cutHor routine measurement 
of digital blood ~ssure and blood ftow. Am J Physiol1977; 232:H338-40. 
3. EichkoffJ. Ishihara S. Jac~n E. Pa~ by stin elecnode. Lancet 1979: 
1:1188.·' -' . 
.. 
.~ 
I 
